Effects of a 12-Week Multimodal Exercise Intervention Among Older Patients with Advanced Cancer: Results from a Randomized Controlled Trial.
advanced cancer
exercise
older patients
randomized controlled trial
resistance training
support
Journal
The oncologist
ISSN: 1549-490X
Titre abrégé: Oncologist
Pays: England
ID NLM: 9607837
Informations de publication
Date de publication:
03 02 2022
03 02 2022
Historique:
received:
12
02
2021
accepted:
25
08
2021
pubmed:
10
9
2021
medline:
21
4
2022
entrez:
9
9
2021
Statut:
ppublish
Résumé
Older patients with cancer are at risk of physical decline and impaired quality of life during oncological treatment. Exercise training has the potential to reduce these challenges. The study aim was to investigate the feasibility and effect of a multimodal exercise intervention in older patients with advanced cancer (stages III/IV). Eighty-four older adults (≥65 years) with advanced pancreatic, biliary tract, or non-small cell lung cancer who received systemic oncological treatment were randomized 1:1 to an intervention group or a control group. The intervention was a 12-week multimodal exercise-based program including supervised exercise twice weekly followed by a protein supplement, a home-based walking program, and nurse-led support and counseling. The primary endpoint was change in physical function (30-second chair stand test) at 13 weeks. Median age of the participants was 72 years (interquartile range [IQR] 68-75). Median adherence to the exercise sessions was 69% (IQR 21-88) and 75% (IQR 33-100) for the walking program. At 13 weeks, there was a significant difference in change scores of 2.4 repetitions in the chair stand test, favoring the intervention group (p < .0001). Furthermore, significant beneficial effects were seen for physical endurance (6-minute walk test), hand grip strength, physical activity, symptom burden, symptoms of depression and anxiety, global health status (quality of life), and lean body mass. No effects were seen for dose intensity, hospitalizations, or survival. A 12-week multimodal exercise intervention with targeted support proved effective in improving physical function in older patients with advanced cancer during oncological treatment.
Sections du résumé
BACKGROUND
Older patients with cancer are at risk of physical decline and impaired quality of life during oncological treatment. Exercise training has the potential to reduce these challenges. The study aim was to investigate the feasibility and effect of a multimodal exercise intervention in older patients with advanced cancer (stages III/IV).
PATIENTS AND METHODS
Eighty-four older adults (≥65 years) with advanced pancreatic, biliary tract, or non-small cell lung cancer who received systemic oncological treatment were randomized 1:1 to an intervention group or a control group. The intervention was a 12-week multimodal exercise-based program including supervised exercise twice weekly followed by a protein supplement, a home-based walking program, and nurse-led support and counseling. The primary endpoint was change in physical function (30-second chair stand test) at 13 weeks.
RESULTS
Median age of the participants was 72 years (interquartile range [IQR] 68-75). Median adherence to the exercise sessions was 69% (IQR 21-88) and 75% (IQR 33-100) for the walking program. At 13 weeks, there was a significant difference in change scores of 2.4 repetitions in the chair stand test, favoring the intervention group (p < .0001). Furthermore, significant beneficial effects were seen for physical endurance (6-minute walk test), hand grip strength, physical activity, symptom burden, symptoms of depression and anxiety, global health status (quality of life), and lean body mass. No effects were seen for dose intensity, hospitalizations, or survival.
CONCLUSION
A 12-week multimodal exercise intervention with targeted support proved effective in improving physical function in older patients with advanced cancer during oncological treatment.
Identifiants
pubmed: 34498352
pii: 6520841
doi: 10.1002/onco.13970
pmc: PMC8842365
doi:
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
67-78Commentaires et corrections
Type : CommentIn
Informations de copyright
© The Author(s) 2022. Published by Oxford University Press.
Références
Integr Cancer Ther. 2018 Dec;17(4):1048-1058
pubmed: 30352523
J Geriatr Oncol. 2018 Jul;9(4):405-410
pubmed: 29606599
J Geriatr Oncol. 2017 Jul;8(4):249-254
pubmed: 28285980
Oncologist. 2011;16(11):1649-57
pubmed: 21948693
Eur Rev Aging Phys Act. 2020 Oct 19;17:18
pubmed: 33088348
Support Care Cancer. 2016 Nov;24(11):4495-502
pubmed: 27236439
Nutr Cancer. 2015;67(7):1056-62
pubmed: 26317149
Arch Phys Med Rehabil. 2013 Dec;94(12):2329-2335
pubmed: 23810356
Dtsch Arztebl Int. 2019 Jul 8;116(27-28):471-478
pubmed: 31431236
BMC Cancer. 2019 Nov 27;19(1):1153
pubmed: 31775667
Curr Opin Support Palliat Care. 2018 Dec;12(4):420-426
pubmed: 30124526
Cancer Treat Rev. 2017 Jan;52:91-104
pubmed: 28006694
J Natl Cancer Inst. 2009 Sep 2;101(17):1206-15
pubmed: 19638506
J Pain Symptom Manage. 2020 Mar;59(3):734-749.e10
pubmed: 31546002
Cochrane Database Syst Rev. 2019 Feb 11;2:CD012685
pubmed: 30741408
J Orthop Sports Phys Ther. 2011 May;41(5):319-27
pubmed: 21335930
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Curr Opin Clin Nutr Metab Care. 2008 Sep;11(5):651-60
pubmed: 18685464
Med Sci Sports Exerc. 2019 Nov;51(11):2375-2390
pubmed: 31626055
Eur J Oncol Nurs. 2019 Aug;41:16-23
pubmed: 31358249
Br J Sports Med. 2016 Jul;50(13):796-803
pubmed: 26719503
Clin Geriatr Med. 2016 Feb;32(1):63-80
pubmed: 26614861
Cancer. 2000 Oct 1;89(7):1634-46
pubmed: 11013380
BMJ. 2010 Mar 23;340:c332
pubmed: 20332509
J Geriatr Oncol. 2016 Jul;7(4):293-304
pubmed: 27197916
J Clin Oncol. 2011 Jan 1;29(1):89-96
pubmed: 21098316
Int J Cancer. 2019 Jan 1;144(1):49-58
pubmed: 29978474
PM R. 2017 Sep;9(9S2):S347-S384
pubmed: 28942909
Integr Cancer Ther. 2020 Jan-Dec;19:1534735420917462
pubmed: 32476493
J Pain Symptom Manage. 2017 Sep;54(3):263-272
pubmed: 28716620
J Gerontol A Biol Sci Med Sci. 2004 Mar;59(3):255-63
pubmed: 15031310
J Natl Cancer Inst. 1993 Mar 3;85(5):365-76
pubmed: 8433390
Cancer. 2012 Mar 1;118(5):1371-86
pubmed: 21953606
Age Ageing. 2019 Jan 1;48(1):16-31
pubmed: 30312372
Pancreas. 2019 Feb;48(2):257-266
pubmed: 30589829
Contemp Clin Trials. 2021 Feb;101:106242
pubmed: 33301991
J Cancer Surviv. 2020 Oct;14(5):689-711
pubmed: 32328828
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
Adv Chronic Kidney Dis. 2010 Jul;17(4):302-7
pubmed: 20610357
Immunol Lett. 2014 Nov;162(1 Pt B):310-5
pubmed: 25014741
Cochrane Database Syst Rev. 2020 May 3;5:CD012864
pubmed: 32361988
Med Sci Sports Exerc. 2019 Jun;51(6):1252-1261
pubmed: 31095082
Support Care Cancer. 2021 Apr;29(4):1781-1794
pubmed: 33106975
Crit Rev Oncol Hematol. 2019 Apr;136:79-85
pubmed: 30878132
Eur J Surg Oncol. 2015 Dec;41(12):1590-602
pubmed: 26358569
J Geriatr Oncol. 2019 Nov;10(6):904-912
pubmed: 31444088
J Pain Symptom Manage. 2019 Nov;58(5):899-908.e7
pubmed: 31319105
BMC Public Health. 2012 Aug 24;12:693
pubmed: 22920914
Cancer Epidemiol Biomarkers Prev. 2016 Jul;25(7):1029-36
pubmed: 27371756
Cancer. 2003 Feb 1;97(3):674-81
pubmed: 12548610
BMC Cancer. 2018 Sep 27;18(1):934
pubmed: 30261853
J Hand Surg Am. 1984 Mar;9(2):222-6
pubmed: 6715829
J Appl Physiol (1985). 2000 Apr;88(4):1321-6
pubmed: 10749826